Researchers track Long-Term safety of experimental eye cancer treatment
Knowledge-focused
Not yet recruiting
This study is a long-term follow-up for 100 people who completed a previous trial of bel-sar, an experimental treatment for early choroidal melanoma (a type of eye cancer). Participants will not receive any new treatment but will be monitored for about 5 more years to check for s…
Sponsor: Aura Biosciences • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:11 UTC